Literature DB >> 15186431

Hyperplasia of dermal microvascular pericytes in scleroderma.

Peter Helmbold1, Eckhard Fiedler, Matthias Fischer, Wolfgang Ch Marsch.   

Abstract

BACKGROUND: Pericytes (PCs) are smooth muscle-like mural cells of capillaries and venules, which can synthesize matrix components and fibroblast-activating cytokines, and are thus potential mediators of pathological changes in scleroderma. In this study, alterations in microvessels were quantitatively imaged, taking PC into account for the first time.
METHODS: Skin biopsies from systemic (12) and localized (14) scleroderma forms as well as age-, sex-, and body location-matched controls were examined with respect to capillary and venular densities as well as endothelial cell (EC) and PC counts using a newly developed (in respect of PC and EC) indirect collagen IV immunostaining-based method.
RESULTS: Hyperplasia of the PC that doubled the microvascular PC density was the most conspicuous characteristic. In the capillaries of the upper dermal plexus of the periphery of the sclerotic zones, median ratios of PC : EC were 0.23 (controls 0.10) or 0.18 (controls 0.11) in systemic or localized scleroderma, respectively. Furthermore, an increase in capillary density in the upper dermal plexus could be demonstrated in the marginal zones of both types of disease.
CONCLUSIONS: The observed PC increase in the peripheral zones of active disease supports the hypothesis of a vascular pathogenesis of scleroderma and directs the focus to microvascular PC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186431     DOI: 10.1111/j.0303-6987.2004.00203.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  14 in total

Review 1.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 2.  The pathogenesis of systemic sclerosis revisited.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  The use of Doppler ultrasound to evaluate lesions of localized scleroderma.

Authors:  Suzanne C Li; Melissa S Liebling
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 4.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 5.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 6.  Causes and consequences of endoplasmic reticulum stress in rheumatic disease.

Authors:  Fatemeh Navid; Robert A Colbert
Journal:  Nat Rev Rheumatol       Date:  2016-12-01       Impact factor: 20.543

7.  Endothelial cell hypertrophy is associated with microvascular occlusion in horse wounds.

Authors:  Valérie Dubuc; Elodie Lepault; Christine L Theoret
Journal:  Can J Vet Res       Date:  2006-07       Impact factor: 1.310

8.  Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures.

Authors:  Suzanne C Li; Melissa S Liebling; Faridali G Ramji; Sven Opitz; Arun Mohanta; Tatiana Kornyat; Shuzhen Zhang; Molly Dempsey-Robertson; Carsten Hamer; Stephanie Edgerton; Jose Jarrin; Mike Malone; Andrea S Doria
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-27       Impact factor: 3.054

Review 9.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 10.  Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.

Authors:  Chadalavada Vijay Krishna; Jagmohan Singh; Chellappagounder Thangavel; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.